Back

Impact Education, Medical Education Resources

  • Carcinoma, Non-Small-Cell Lung
  • Immune Checkpoint Inhibitors

Managed Care Review Board Presents: Health Plan Best Practice Insights to Improve Outcomes for Non-Small Cell Lung Cancer On Demand Webcast

This on-demand activity will help to inform managed care professionals about the latest clinical, economic, and policy insights in the management of non-small cell lung cancer (NSCLC). Participants will explore current screening and treatment guidelines, the value of biomarker-driven therapies, and the cost-effectiveness of emerging options such as immune checkpoint inhibitors and next-generation sequencing. The program also addresses real-world challenges including disparities in care, diagnostic delays, and coverage barriers. Through expert-led discussions and case examples, attendees will gain actionable strategies to align evidence-based treatment with value-based care, improve care coordination, and optimize outcomes for patients with NSCLC.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.25 creditsNursingUp to 1.25 creditsPharmacyUp to 1.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Conference / congress
  • includes On-demand / recorded video
  • Credit · Up to 1.25 credits
  • Commercial Support
  • Released
    Oct 1, 2025
  • Last day to claim credit
    May 1, 2027 7 months left